These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 7008367

  • 1. [The influence of therapy with silymarin on the survival rate of patients with liver cirrhosis (author's transl)].
    Benda L, Dittrich H, Ferenzi P, Frank H, Wewalka F.
    Wien Klin Wochenschr; 1980 Oct 10; 92(19):678-83. PubMed ID: 7008367
    [Abstract] [Full Text] [Related]

  • 2. Use of the Romanian product Silimarina in the treatment of chronic liver diseases.
    Tănăsescu C, Petrea S, Băldescu R, Macarie E, Chiriloiu C, Purice S.
    Med Interne; 1988 Oct 10; 26(4):311-22. PubMed ID: 3072661
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical investigation of silymarin in chronic liver diseases (author's transl)].
    Realini S, Gonvers JJ, Hofstetter JR.
    Schweiz Rundsch Med Prax; 1975 May 13; 64(19):595-8. PubMed ID: 51497
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients].
    Trinchet JC, Coste T, Lévy VG, Vivet F, Duchatelle V, Legendre C, Gotheil C, Beaugrand M.
    Gastroenterol Clin Biol; 1989 May 13; 13(2):120-4. PubMed ID: 2707520
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hepatoprotective and immunomodulatory effects of antioxidant therapy.
    Láng I, Deák G, Nékám K, Müzes G, González-Cabello R, Gergely P, Fehér J.
    Acta Med Hung; 1988 May 13; 45(3-4):287-95. PubMed ID: 3074277
    [Abstract] [Full Text] [Related]

  • 11. [Therapeutic effect of silymarin in patients with liver cirrhosis].
    Kupcová V, Turecký L, Holomán J, Ulicná O, Brixová E, Volmut J.
    Cas Lek Cesk; 1987 Nov 06; 126(45):1406-9. PubMed ID: 3427593
    [No Abstract] [Full Text] [Related]

  • 12. Colchicine in the treatment of cirrhosis of the liver.
    Kershenobich D, Vargas F, Garcia-Tsao G, Perez Tamayo R, Gent M, Rojkind M.
    N Engl J Med; 1988 Jun 30; 318(26):1709-13. PubMed ID: 3287167
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol)].
    Müzes G, Deák G, Láng I, Nékám K, Niederland V, Fehér J.
    Orv Hetil; 1990 Apr 22; 131(16):863-6. PubMed ID: 2345633
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Colchicine therapy of fibrosing liver diseases--report of a randomized double-blind study].
    Reinhardt M, Jorke D, Jahn G, Krombholz B, Müller A, Machnik G, Kunath H.
    Dtsch Z Verdau Stoffwechselkr; 1986 Apr 22; 46(5):257-75. PubMed ID: 3542496
    [Abstract] [Full Text] [Related]

  • 18. Hepatoprotective and immunological effects of antioxidant drugs.
    Láng I, Nékám K, González-Cabello R, Mũzes G, Gergely P, Fehér J.
    Tokai J Exp Clin Med; 1990 May 22; 15(2-3):123-7. PubMed ID: 1983370
    [Abstract] [Full Text] [Related]

  • 19. [Silymarin in chronic liver diseases].
    Müscher CH.
    Ther Ggw; 1972 Dec 22; 111(12):1768-70 passim. PubMed ID: 4569030
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.